About Recode Therapeutics
Recode Therapeutics is a private company based in Menlo Park, California. It has reported $318,741,320 raised in four offerings on Form D since January 2017.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Sep 23, 2025 | Oct 23, 2025 | $29,441,931fully sold | 26 | $1.1M | DebtRule 506(b) | Form D ↗ |
| Oct 13, 2021 | Oct 25, 2021amended Sep 28, 2023 | $259,799,396of $290.0M target | 28 | $9.2M | EquityRule 506(b) | Form D/A ↗3 earlier filings |
| Mar 6, 2020 | Mar 20, 2020 | $27,499,993of $79.9M target | 9 | $3.0M | EquityRule 506(b) | Form D ↗ |
| Dec 16, 2016 | Jan 5, 2017amended Feb 8, 2019 | $2,000,000of $3.0M target | 1 | $2.0M | EquityRule 506(b) | Form D/A ↗2 earlier filings |
| Total, four offerings | $318,741,320 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Recode Therapeutics's Form D filed Oct 23, 2025.
RH
Rana Al-Hallaq
Director
PM
Patricia Millican
Director
SS
Shehnaaz Suliman
Executive officer and director
EH
Edward Hurwitz
Director
AC
DL
David Lockhart
Executive officer
DM
Dean Mitchell
Director
BZ
Basheer Zada
Director
IP
Inai Park
Director
HK
PT
Peter Thompson
Director
Rakhshita Dhar
Director
Also a director at Deka Biosciences and SonoThera and a board member at NextPoint Therapeutics.
Earlier filings also listed Trisha Millican (director, last listed Sep 2023), Oleg Nodelman (director, last listed Sep 2023), Kouki Harasaki (director, last listed Sep 2023), Ra Session II (director, last listed Mar 2020), Michael Torres (director, last listed Mar 2020) and Arthur Johnson (president and director, last listed Feb 2019).
Sources
- SECRECODE THERAPEUTICS, INC. Form D/A, filed Jan 27, 2023
- SECRECODE THERAPEUTICS, INC. Form D/A, filed Jul 6, 2022
- SECRECODE THERAPEUTICS, INC. Form D, filed Oct 25, 2021
- SECRECODE THERAPEUTICS, INC. Form D/A, filed Mar 2, 2017
- SECRECODE THERAPEUTICS, INC. Form D, filed Jan 5, 2017
- SECRECODE THERAPEUTICS, INC. filing history